Email this article Prediction of ischemic stroke outcome during thrombolytic therapy
- Authors: Minina Y.D.1, Kalinin V.A.2
-
Affiliations:
- Samara Regional Clinical Hospital named after V.D. Seredavin
- Samara State Medical University
- Issue: Vol 5, No 4 (2020)
- Pages: 245-250
- Section: Diseases of the nervous system
- URL: https://medbiosci.ru/2500-1388/article/view/53066
- DOI: https://doi.org/10.35693/2500-1388-2020-5-4-245-250
- ID: 53066
Cite item
Full Text
Abstract
The problem of ischemic stroke in the Russian Federation occupies a leading place in the structure of causes of mortality. Among all treatment methods, the systemic thrombolytic therapy with a recombinant tissue plasminogen activator is regarded as the most effective one.
This review focuses on clinical studies of the safety and effectiveness of this type of treatment, as well as on prognostically unfavorable factors inducing the hemorrhagic transformation of ischemic stroke.
Full Text
##article.viewOnOriginalSite##About the authors
Yu. D. Minina
Samara Regional Clinical Hospital named after V.D. Seredavin
Author for correspondence.
Email: jminina1988@gmail.com
ORCID iD: 0000-0002-2992-6451
neurologist
Russian Federation, SamaraV. A. Kalinin
Samara State Medical University
Email: jminina1988@gmail.com
ORCID iD: 0000-0003-3233-8324
PhD, Professor of Department of neurology and neurosurgery
Russian Federation, SamaraSupplementary files
